Compare Neurocrine Biosciences Inc (NBIX) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Impinj Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Impinj Inc trades at $137.09 (market cap $4.19B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.2× Impinj Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | PI | |
|---|---|---|
Market Cap | $17.40B | $4.19B |
Sector | Health | Technology |
52-Week High | $180.55 | $241.91 |
52-Week Low | $123.10 | $91.34 |
Enterprise Value | $16.49B | $4.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
